The first Rare Disease Fair — Seattle
The NW Rare Disease Coalition hosts the first fair in Seattle, bringing the Pacific Northwest's rare disease community into one room for the first time.
Rare disease families shouldn't have to live in the right state to be seen. Our events put every part of a state's rare disease ecosystem in one room — patient advocates, patient organizations, researchers, clinicians, genetic counselors, industry, government institutions, payers, and legislators — to end the diagnostic odyssey, improve access to care, and accelerate new treatments.
A full day of panels, keynotes, breakout sessions, and community tables that puts a state's entire rare disease ecosystem in one room — with action-oriented discussions around the diagnostic odyssey, genetic testing, and gene therapy.
A payer-centered convening that brings health insurers, clinicians, researchers, biotech leaders, and patient advocates together for open, constructive conversation about rare disease care.
A day connecting researchers with the community to accelerate the science — launched alongside the Colorado fair in 2026.
The NW Rare Disease Coalition hosts the first fair in Seattle, bringing the Pacific Northwest's rare disease community into one room for the first time.
Annual Seattle fairs grow year over year, adding Payer Forums and community picnics — and showing that when a state's whole ecosystem convenes, real collaboration follows.
Colorado becomes the first fair beyond the Northwest, followed by Oklahoma — proving the model works in any state that's ready to show up. Research Days join the lineup.
To take the fairs national, the team behind them forms the Rare Disease Alliance — a national 501(c)(3) that pilots programs, generates evidence, builds statewide coalitions, and advances state policy so breakthroughs in one state spread to all of them.
Texas, North Carolina, and California host inaugural events while Seattle celebrates its 10th annual fair. We won't stop until every state convenes for its rare disease families.
Whether you're a rare disease family, a clinician, a researcher, an industry partner, a payer, or a policymaker — we'd love to hear from you.